What is the benefit of aspirin for primary prevention of IS in women?
A large, sex-specific meta-analysis of aspirin for primary prevention of IS (separate from other cardiovascular events) showed that women appeared to benefit from aspirin (OR, 0.76; 95% CI, 0.63 0.93), whereas men showed no benefit.